Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data

BACKGROUND: Proteinuria is a common adverse effect of vascular endothelial growth factor targeted agents, particularly in metastatic renal cell carcinoma (mRCC). However, risk factors for proteinuria are poorly defined. METHODS: Data on 1392 mRCC patients using pazopanib or sunitinib were pooled fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorich, Michael J, Rowland, Andrew, Kichenadasse, Ganessan, Woodman, Richard J, Mangoni, Arduino A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984472/
https://www.ncbi.nlm.nih.gov/pubmed/27228299
http://dx.doi.org/10.1038/bjc.2016.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984472/
https://www.ncbi.nlm.nih.gov/pubmed/27228299
http://dx.doi.org/10.1038/bjc.2016.147

Ejemplares similares